Lavinia Balan

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Coronavirus Disease

Advanced Non Small Cell Lung Cancer

Magnetic Resonance

Systematic Review

Top Venues

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Lavinia Balan, Anca Maria Cîmpean, Prashant Sunil Nandarge, Bogdan Sorop, Catalin Balan, Madalina Alexandra Balica, Felix Bratosin, Simona Brasoveanu, Madalina Boruga, Laurentiu Pirtea
Clinical Outcomes and Molecular Predictors of Pembrolizumab (Keytruda) as a PD-1 Immune Checkpoint Inhibitor in Advanced and Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis. Biomedicines 12 (5) (2024)
Lavinia Balan, Cristina Secoșan, Virgiliu-Bogdan Sorop, Marilena Pirtea, Anca Maria Cîmpean, Daniela Chiriac, Catalin Balan, Ema Borsi, Ariana Iorga, Laurentiu Pirtea
Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Lavinia Balan, Cristina Secoșan, Virgiliu-Bogdan Sorop, Marilena Pirtea, Anca Maria Cîmpean, Daniela Chiriac, Catalin Balan, Ema Borsi, Ariana Iorga, Laurentiu Pirtea
Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study. Medicina (Kaunas, Lithuania) 60 (6) (2024)
Lavinia Balan, Anca Maria Cîmpean, Prashant Sunil Nandarge, Bogdan Sorop, Catalin Balan, Madalina Alexandra Balica, Felix Bratosin, Simona Brasoveanu, Madalina Boruga, Laurentiu Pirtea
Clinical Outcomes and Molecular Predictors of Pembrolizumab (Keytruda) as a PD-1 Immune Checkpoint Inhibitor in Advanced and Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis. Biomedicines 12 (5) (2024)